Drug Transfer Device Market Size, Share & Growth Report 2031

Drug Transfer Device Market Size, Share & Growth Report 2031

Segments - Global Drug Transfer Device Market by Types (Membrane-to-Membrane Systems and Needleless Systems), Components (Closed Bag/Line Access Devices, Closed Vial Access Devices, and Closed Syringe Safety Devices), Technology (Diaphragm-Based Devices, Compartmentalized Devices, and Air Cleaning/Filtration Devices), End-users (Specialty Centers, Hospitals, Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 - 2027

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2589 | 4.3 Rating | 77 Reviews | 265 Pages | Format : PDF Excel PPT

Report Description


Drug Transfer Device Market Outlook

The global drug transfer device market was valued at USD 392.6 Mn in 2019 and is projected to reach USD 1,767.4 Mn by 2027, expanding at a CAGR of 21.2% during the forecast period. The market is driven by the rising number of cancer cases and increasing adoption of chemotherapy are anticipated to drive the demand for the drug transfer device market. Growth of drug transfer devices is attributed to combat the harmful effects of antineoplastic drugs.

Drug transfer device mechanically forbids the transfer of environmental impurities into the system and the escape of the hazardous drug. The drug transfer devices are those which prevent drug leak at the time of patient treatment. The drug leak can take place at the time of reconstitution, administration of the drug to the patient or compounding.

 Drug Transfer Device Market Market Outlook

Pharmacists, physicians, nurses, and other healthcare workers come in contact with several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics during cancer treatments. Adoption of drug transfer devices has witnessed growth, as it reduces surface contamination and closes routes of exposure.

Drug Transfer Device Market Dynamics

Drug transfer devices are devices designed to prevent the transfer of contaminants into the environment during drug transfer between the vial and syringe, by maintaining a closed connection. Rising number of cancer cases and increasing adoption of chemotherapy are anticipated to drive the demand for the drug transfer device market.

Pharmacists, physicians, nurses, and other healthcare workers come in contact with several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics during cancer treatments. Traces of these drugs have been found in unlikely places like doorknobs, keyboards, and other surfaces. It also affects the patients and their families and other hospital staff.

Recent discoveries in cancer and oncology has led to new treatment approaches and drugs. Yet cancer exists with unmet medical needs. Regulatory authorities such as the FDA have now begun to show flexibility towards the approval of drugs and have come up with new and creative ways of measuring the suitability of cancer drugs. This has led to a substantial surge in the speed of approval of new drugs.

Vial adaptor is a drug transfer device that connects vial to syringe or vial to vial, enabling the mixing and/or transfer of the drug (to be administered to the patient thereafter). Although there are many ISO standards for infusion transfer devices, these do not necessarily apply to vial adaptors. When healthcare sites criticize about issues with vial adaptors, no standards exist to support the issues. Vial adaptor manufacturers want to design products that achieve user and patient safety, but lack quantitative specifications to test their devices in real-world conditions.

Hence, lack of detailed guidelines and inefficiency of drug transfer products especially in emerging nations and restrain the market. According to National Medical Products Administration, around 10 million healthcare personnel in China are exposed to hazardous drugs annually, due to lack of government policies and proper guidelines regarding drug transfer devices.


Drug transfer devices are additional engineering controls designed to reduce occupational exposure of hazardous drugs. They are constantly implemented in accordance with changing regulations. A significant number of drug transfer devices are now commercially available. They comprise different materials of construction, lubricants, fluid path, and holdup volumes.

A detailed compatibility study with each type of commercial drug transfer device and investigational drug products is difficult and significantly extends timelines for product development. Health authority feedback regarding the use of drug transfer devices for investigational drug products is needed to ensure compliance, especially for patient safety while balancing risk and benefit to the health care personnel. This is expected to provide opportunities for market growth.

Drug Transfer Device Market Segmental Outlook

Based on types, the global drug transfer device market is segmented into membrane-to-membrane systems and needleless systems. The membrane-to-membrane segment is expected to grow at a significant rate during the forecast period. The presence of double membrane for transfusion of medication provides an added layer of protection compared to needleless membranes, which fuels the membrane-to-membrane segment.

 Drug Transfer Device Market Types

In terms of components, the global drug transfer device market is segmented into closed bag/line access devices, closed vial access devices, and closed syringe safety devices. The closed vial access devices segment is estimated to expand during the forecast period. Closed vial access devices help in storing a drug for up to a week. The closed vial access device segment is expected to grow at a substantial pace during the forecast period.

Based on technologies, the global drug transfer device market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. The diaphragm-based devices segment is anticipated to expand at a significant pace in the coming years. The diaphragm-based devices segment dominated the market during 2019 and held a key share of the market.

The segment is projected to expand at a considerable pace during the forecast period owing to the safety provided by these device and ease of operation. The compartmentalized devices segment is estimated to expand at a rapid pace due to its cost-effectiveness.

 Drug Transfer Device Market Technologies

In terms of end-users, the global drug transfer device market is segregated into specialty centers, hospitals, clinics, and others. The hospitals segment is expected to lead the market during forecast, as patients prefer to visit hospitals due to the presence of doctors and medical staff and equipment for treatment under one roof. Accessibility of diagnostic centers in the clinic is helpful for patients as they can be diagnosed and tested at the same place. The clinics are less expensive.

However, non-availability of services 24*7 may hinder the growth of clinic segment in the drug transfer device market. The specialty centers segment is likely to expand at a significant pace owing to the rise in pulmonary diseases, cancers, and hormonal disorders. The specialty center segment is estimated to expand with a substantial CAGR during the forecast period.

Drug Transfer Device Market Regional Outlook

On the basis of regions, the global drug transfer device market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds a major share of the market and this trend is expected to continue during the forecast period. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period.

The growth of the market in Asia Pacific is attributed to the increasing number of cancer cases and rising demand for improved healthcare services in developing countries such as China and India. The drug transfer devices market is projected to grow due to technological advancements, investments in research & development, and rising awareness about the DTDs among people.

 Drug Transfer Device Market Region

Key Benefits for Industry Participants & Stakeholders

  • In-depth analysis of the global drug transfer device market
  • Historical, current, and projected market size in terms of value (USD million) and volume (tons)
  • Potential & niche segments and regions exhibiting promising growth covered
  • Industry drivers, restraints, and opportunities covered in the study
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Neutral perspective on global sulfonated asphalt market performance

Segments

By Types

  • Membrane-to-membrane Systems
  • Needleless Systems

By Components

  • Closed Bag/Line Access Devices
  • Closed Vial Access Devices
  • Closed Syringe Safety Devices

By Technologies

  • Diaphragm-based Devices
  • Compartmentalized Devices
  • Air Cleaning/Filtration Devices

By End-Users

  • Specialty Centers
  • Hospitals
  • Clinics
  • Others

By Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Market Players Profiled in the Report

Competitive Landscape

  • Prominent manufacturers operating in the drug transfer device market includes B. Braun Medical Inc., BD, Caragen Ltd., Corvida Medical, Epic Medical, Equashield LLC., ICU Medical, Inc., JMS Co Ltd, Simplivia Healthcare, West Pharmaceutical, and Yukon Medical.
  • These companies are considered as key manufacturers of sulfonated asphalt based on their revenue, research & development (R&D) activities, regional presence, and supply chain management system.

 Drug Transfer Device Market Key Players

Frequently Asked Questions

Major Manufactures are B. Braun Medical Inc., BD, Equashield LLC., ICU Medical, Inc., and JMS Co Ltd.

The base year considered for the global drug transfer device market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.

COVID- 19 has several positive and negative impacts on the world economy. Economic activities have come to a stand-still, as countries imposed harsh restrictions to curb the spread of coronavirus. This has left a long-lasting damage on the world economy.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

The market is driven by the increasing use of chemotherapy in cancer patients, and high demand for administration of antineoplastic drugs.

The applications in the global drug transfer device market includes Specialty Centers, Hospitals, Clinics, and Others

In addition to market size (in USD Million) & market volume (in Mn Units), company market share (in % for base year 2019), other data such as regulatory outlook, Medical Devices Industry Outlook, macro-economic factors and COVID-19 impact on the value chain are available in the final report.

According to the Growth Market Reports, the market for drug transfer device is likely to register a CAGR of 21.2% during forecast period 2020-2027, with an anticipated valuation of USD 1,767.4 million by the end of 2027.

Yes, the report provides supply chain analysis along with a list of raw material suppliers, manufacturers, distributors, and customers.

Additional company profiles can be provided on request.

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Transfer Device Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Drug Transfer Device Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Drug Transfer Device Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Drug Transfer Device Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Drug Transfer Device Market Size & Volume & Forecast, 2017-2027
      4.5.1 Drug Transfer Device Market Size & Volume and Y-o-Y Growth
      4.5.2 Drug Transfer Device Market Absolute $ Opportunity
   4.6 Global Drug Transfer Device Market: Impact Of Key Regulations

   4.7 Medical Devices Industry Outlook
Chapter 5 Global Drug Transfer Device Market Analysis and Forecast By Types
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Types
      5.1.2 Basis Point Shares (BPS) Analysis By Types
      5.1.3 Absolute $ Opportunity Assessment By Types
   5.2 Drug Transfer Device Market Size & Volume Forecast By Types
      5.2.1 Membrane-to-Membrane Systems
      5.2.2 Needleless Systems
   5.3 Market Attractiveness Analysis By Types
Chapter 6 Global Drug Transfer Device Market Analysis and Forecast By Components
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Components
      6.1.2 Basis Point Share (BPS) Analysis By Components
      6.1.3 Absolute $ Opportunity Assessment By Components
   6.2 Drug Transfer Device Market Size & Volume Forecast By Components
      6.2.1 Closed Bag/Line Access Devices
      6.2.2 Closed Vial Access Devices
      6.2.3 Closed Syringe Safety Devices
   6.3 Market Attractiveness Analysis By Components
Chapter 7 Global Drug Transfer Device Market Analysis and Forecast By Technologies
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Technologies
      7.1.2 Basis Point Share (BPS) Analysis By Technologies
      7.1.3 Absolute $ Opportunity Assessment By Technologies
   7.2 Drug Transfer Device Market Size & Volume Forecast By Technologies
      7.2.1 Diaphragm-Based Devices
      7.2.2 Compartmentalized Devices
      7.2.3 Air Cleaning/Filtration Devices
   7.3 Market Attractiveness Analysis By Technologies
Chapter 8 Global Drug Transfer Device Market Analysis and Forecast By End-Users
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By End-Users
      8.1.2 Basis Point Share (BPS) Analysis By End-Users
      8.1.3 Absolute $ Opportunity Assessment By End-Users
   8.2 Drug Transfer Device Market Size & Volume Forecast By End-Users
      8.2.1 Specialty Centers
      8.2.2 Hospitals
      8.2.3 Clinics
      8.2.4 Others
   8.3 Market Attractiveness Analysis By End-Users
Chapter 9 Global Drug Transfer Device Market Analysis and Forecast by Region
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities by Region
      9.1.2 Basis Point Share (BPS) Analysis by Region
      9.1.3 Absolute $ Opportunity Assessment by Region
   9.2 Drug Transfer Device Market Size & Volume Forecast by Region
      9.2.1 North America
      9.2.2 Europe
      9.2.3 Asia Pacific
      9.2.4 Latin America
      9.2.5 Middle East & Africa (MEA)
   9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
   10.1 Introduction
   10.2 Current & Future Impact Analysis
   10.3 Economic Impact Analysis
   10.4 Government Policies
   10.5 Investment Scenario
Chapter 11 North America Drug Transfer Device Analysis and Forecast
   11.1 Introduction
   11.2 North America Drug Transfer Device Market Size & Volume Forecast by Country
      11.2.1 U.S.
      11.2.2 Canada
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 North America Drug Transfer Device Market Size & Volume Forecast By Types
      11.6.1 Membrane-to-Membrane Systems
      11.6.2 Needleless Systems
   11.7 Basis Point Share (BPS) Analysis By Types
   11.8 Absolute $ Opportunity Assessment By Types
   11.9 Market Attractiveness Analysis By Types
   11.10 North America Drug Transfer Device Market Size & Volume Forecast By Components
      11.10.1 Closed Bag/Line Access Devices
      11.10.2 Closed Vial Access Devices
      11.10.3 Closed Syringe Safety Devices
   11.11 Basis Point Share (BPS) Analysis By Components
   11.12 Absolute $ Opportunity Assessment By Components
   11.13 Market Attractiveness Analysis By Components
   11.14 North America Drug Transfer Device Market Size & Volume Forecast By Technologies
      11.14.1 Diaphragm-Based Devices
      11.14.2 Compartmentalized Devices
      11.14.3 Air Cleaning/Filtration Devices
   11.15 Basis Point Share (BPS) Analysis By Technologies
   11.16 Absolute $ Opportunity Assessment By Technologies
   11.17 Market Attractiveness Analysis By Technologies
   11.18 North America Drug Transfer Device Market Size & Volume Forecast By End-Users
      11.18.1 Specialty Centers
      11.18.2 Hospitals
      11.18.3 Clinics
      11.18.4 Others
   11.19 Basis Point Share (BPS) Analysis By End-Users
   11.20 Absolute $ Opportunity Assessment By End-Users
   11.21 Market Attractiveness Analysis By End-Users
Chapter 12 Europe Drug Transfer Device Analysis and Forecast
   12.1 Introduction
   12.2 Europe Drug Transfer Device Market Size & Volume Forecast by Country
      12.2.1 Germany
      12.2.2 France
      12.2.3 Italy
      12.2.4 U.K.
      12.2.5 Spain
      12.2.6 Russia
      12.2.7 Rest of Europe
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Europe Drug Transfer Device Market Size & Volume Forecast By Types
      12.6.1 Membrane-to-Membrane Systems
      12.6.2 Needleless Systems
   12.7 Basis Point Share (BPS) Analysis By Types
   12.8 Absolute $ Opportunity Assessment By Types
   12.9 Market Attractiveness Analysis By Types
   12.10 Europe Drug Transfer Device Market Size & Volume Forecast By Components
      12.10.1 Closed Bag/Line Access Devices
      12.10.2 Closed Vial Access Devices
      12.10.3 Closed Syringe Safety Devices
   12.11 Basis Point Share (BPS) Analysis By Components
   12.12 Absolute $ Opportunity Assessment By Components
   12.13 Market Attractiveness Analysis By Components
   12.14 Europe Drug Transfer Device Market Size & Volume Forecast By Technologies
      12.14.1 Diaphragm-Based Devices
      12.14.2 Compartmentalized Devices
      12.14.3 Air Cleaning/Filtration Devices
   12.15 Basis Point Share (BPS) Analysis By Technologies
   12.16 Absolute $ Opportunity Assessment By Technologies
   12.17 Market Attractiveness Analysis By Technologies
   12.18 Europe Drug Transfer Device Market Size & Volume Forecast By End-Users
      12.18.1 Specialty Centers
      12.18.2 Hospitals
      12.18.3 Clinics
      12.18.4 Others
   12.19 Basis Point Share (BPS) Analysis By End-Users
   12.20 Absolute $ Opportunity Assessment By End-Users
   12.21 Market Attractiveness Analysis By End-Users
Chapter 13 Asia Pacific Drug Transfer Device Analysis and Forecast
   13.1 Introduction
   13.2 Asia Pacific Drug Transfer Device Market Size & Volume Forecast by Country
      13.2.1 China
      13.2.2 Japan
      13.2.3 South Korea
      13.2.4 India
      13.2.5 Australia
      13.2.6 South East Asia (SEA)
      13.2.7 Rest of Asia Pacific (APAC)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By Types
      13.6.1 Membrane-to-Membrane Systems
      13.6.2 Needleless Systems
   13.7 Basis Point Share (BPS) Analysis By Types
   13.8 Absolute $ Opportunity Assessment By Types
   13.9 Market Attractiveness Analysis By Types
   13.10 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By Components
      13.10.1 Closed Bag/Line Access Devices
      13.10.2 Closed Vial Access Devices
      13.10.3 Closed Syringe Safety Devices
   13.11 Basis Point Share (BPS) Analysis By Components
   13.12 Absolute $ Opportunity Assessment By Components
   13.13 Market Attractiveness Analysis By Components
   13.14 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By Technologies
      13.14.1 Diaphragm-Based Devices
      13.14.2 Compartmentalized Devices
      13.14.3 Air Cleaning/Filtration Devices
   13.15 Basis Point Share (BPS) Analysis By Technologies
   13.16 Absolute $ Opportunity Assessment By Technologies
   13.17 Market Attractiveness Analysis By Technologies
   13.18 Asia Pacific Drug Transfer Device Market Size & Volume Forecast By End-Users
      13.18.1 Specialty Centers
      13.18.2 Hospitals
      13.18.3 Clinics
      13.18.4 Others
   13.19 Basis Point Share (BPS) Analysis By End-Users
   13.20 Absolute $ Opportunity Assessment By End-Users
   13.21 Market Attractiveness Analysis By End-Users
Chapter 14 Latin America Drug Transfer Device Analysis and Forecast
   14.1 Introduction
   14.2 Latin America Drug Transfer Device Market Size & Volume Forecast by Country
      14.2.1 Brazil
      14.2.2 Mexico
      14.2.3 Rest of Latin America (LATAM)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Latin America Drug Transfer Device Market Size & Volume Forecast By Types
      14.6.1 Membrane-to-Membrane Systems
      14.6.2 Needleless Systems
   14.7 Basis Point Share (BPS) Analysis By Types
   14.8 Absolute $ Opportunity Assessment By Types
   14.9 Market Attractiveness Analysis By Types
   14.10 Latin America Drug Transfer Device Market Size & Volume Forecast By Components
      14.10.1 Closed Bag/Line Access Devices
      14.10.2 Closed Vial Access Devices
      14.10.3 Closed Syringe Safety Devices
   14.11 Basis Point Share (BPS) Analysis By Components
   14.12 Absolute $ Opportunity Assessment By Components
   14.13 Market Attractiveness Analysis By Components
   14.14 Latin America Drug Transfer Device Market Size & Volume Forecast By Technologies
      14.14.1 Diaphragm-Based Devices
      14.14.2 Compartmentalized Devices
      14.14.3 Air Cleaning/Filtration Devices
   14.15 Basis Point Share (BPS) Analysis By Technologies
   14.16 Absolute $ Opportunity Assessment By Technologies
   14.17 Market Attractiveness Analysis By Technologies
   14.18 Latin America Drug Transfer Device Market Size & Volume Forecast By End-Users
      14.18.1 Specialty Centers
      14.18.2 Hospitals
      14.18.3 Clinics
      14.18.4 Others
   14.19 Basis Point Share (BPS) Analysis By End-Users
   14.20 Absolute $ Opportunity Assessment By End-Users
   14.21 Market Attractiveness Analysis By End-Users
Chapter 15 Middle East & Africa (MEA) Drug Transfer Device Analysis and Forecast
   15.1 Introduction
   15.2 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast by Country
      15.2.1 Saudi Arabia
      15.2.2 South Africa
      15.2.3 UAE
      15.2.4 Rest of Middle East & Africa (MEA)
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By Types
      15.6.1 Membrane-to-Membrane Systems
      15.6.2 Needleless Systems
   15.7 Basis Point Share (BPS) Analysis By Types
   15.8 Absolute $ Opportunity Assessment By Types
   15.9 Market Attractiveness Analysis By Types
   15.10 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By Components
      15.10.1 Closed Bag/Line Access Devices
      15.10.2 Closed Vial Access Devices
      15.10.3 Closed Syringe Safety Devices
   15.11 Basis Point Share (BPS) Analysis By Components
   15.12 Absolute $ Opportunity Assessment By Components
   15.13 Market Attractiveness Analysis By Components
   15.14 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By Technologies
      15.14.1 Diaphragm-Based Devices
      15.14.2 Compartmentalized Devices
      15.14.3 Air Cleaning/Filtration Devices
   15.15 Basis Point Share (BPS) Analysis By Technologies
   15.16 Absolute $ Opportunity Assessment By Technologies
   15.17 Market Attractiveness Analysis By Technologies
   15.18 Middle East & Africa (MEA) Drug Transfer Device Market Size & Volume Forecast By End-Users
      15.18.1 Specialty Centers
      15.18.2 Hospitals
      15.18.3 Clinics
      15.18.4 Others
   15.19 Basis Point Share (BPS) Analysis By End-Users
   15.20 Absolute $ Opportunity Assessment By End-Users
   15.21 Market Attractiveness Analysis By End-Users

Chapter 16 Competition Landscape
   16.1 Drug Transfer Device Market: Competitive Dashboard
   16.2 Global Drug Transfer Device Market: Market Share Analysis, 2019
   16.3 Company Profiles (Details - Overview, Financials, Developments, Strategy)
      16.3.1 B. Braun Medical Inc.
      16.3.2 BD
      16.3.3 Caragen Ltd.
      16.3.4 Corvida Medical
      16.3.5 Epic Medical
      16.3.6 Equashield LLC.
      16.3.7 ICU Medical, Inc.
      16.3.8 JMS Co Ltd
      16.3.9 Simplivia Healthcare
      16.3.10 West Pharmaceutical
      16.3.11 Yukon Medical
      16.3.12 Company 12
      16.3.13 Company 13
      16.3.14 Company 14
      16.3.15 Company 15

Methodology

Our Clients

Pfizer
Dassault Aviation
FedEx Logistics
Microsoft
The John Holland Group
Honda Motor Co. Ltd.
sinopec
Nestle SA